CN103360452B - 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 - Google Patents
甜瓜蒂四环三萜葫芦素类化合物的制备和应用 Download PDFInfo
- Publication number
- CN103360452B CN103360452B CN201210097676.8A CN201210097676A CN103360452B CN 103360452 B CN103360452 B CN 103360452B CN 201210097676 A CN201210097676 A CN 201210097676A CN 103360452 B CN103360452 B CN 103360452B
- Authority
- CN
- China
- Prior art keywords
- compound
- cucurbitane
- preparation
- compounds
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 triterpene cucurbitane compound Chemical class 0.000 title claims abstract description 29
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 title abstract description 17
- 244000064895 Cucumis melo subsp melo Species 0.000 title description 17
- 230000015572 biosynthetic process Effects 0.000 title description 2
- 238000003786 synthesis reaction Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 40
- 239000003814 drug Substances 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 15
- 238000000746 purification Methods 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 8
- CVKKIVYBGGDJCR-SXDZHWHFSA-N Cucurbitacin B Natural products CC(=O)OC(C)(C)C=CC(=O)[C@@](C)(O)[C@@H]1[C@@H](O)C[C@]2(C)C3=CC[C@@H]4C(C)(C)C(=O)[C@H](O)C[C@@]4(C)[C@@H]3CC(=O)[C@@]12C CVKKIVYBGGDJCR-SXDZHWHFSA-N 0.000 abstract description 7
- 239000002904 solvent Substances 0.000 abstract description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000741 silica gel Substances 0.000 abstract description 6
- 229910002027 silica gel Inorganic materials 0.000 abstract description 6
- 229960001866 silicon dioxide Drugs 0.000 abstract description 6
- 239000007791 liquid phase Substances 0.000 abstract description 5
- LNSXRXFBSDRILE-UHFFFAOYSA-N Cucurbitacin Natural products CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C)(C)C(O)C(O)CC4(C)C3(C)C(=O)CC12C LNSXRXFBSDRILE-UHFFFAOYSA-N 0.000 abstract description 4
- 150000001904 cucurbitacins Chemical class 0.000 abstract description 4
- PIGAXYFCLPQWOD-UHFFFAOYSA-N dihydrocucurbitacin I Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C PIGAXYFCLPQWOD-UHFFFAOYSA-N 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 244000241257 Cucumis melo Species 0.000 abstract 1
- 241000235070 Saccharomyces Species 0.000 abstract 1
- 230000002605 anti-dotal effect Effects 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 210000005253 yeast cell Anatomy 0.000 description 9
- 206010039966 Senile dementia Diseases 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000018991 trans-resveratrol Nutrition 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IXQKXEUSCPEQRD-NRNCYQGDSA-N (2S,4R,23E)-2,16beta,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(C)OC(=O)C)C=C2[C@H]1C[C@H](O)C(=O)C2(C)C IXQKXEUSCPEQRD-NRNCYQGDSA-N 0.000 description 3
- UZEAHFLEZWXHCE-UHFFFAOYSA-N 3-iodo-2-methylaniline Chemical compound CC1=C(N)C=CC=C1I UZEAHFLEZWXHCE-UHFFFAOYSA-N 0.000 description 3
- IHTCCHVMPGDDSL-ZJNDIJRCSA-N Cucurbitacin A Natural products O=C([C@@](O)(C)[C@H]1[C@@H](O)C[C@]2(C)[C@]1(C)CC(=O)[C@]1(CO)[C@H]2CC=C2C(C)(C)C(=O)[C@H](O)C[C@@H]12)/C=C/C(OC(=O)C)(C)C IHTCCHVMPGDDSL-ZJNDIJRCSA-N 0.000 description 3
- QZJJDOYZVRUEDY-UHFFFAOYSA-N Dihydrocucurbitacin B Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)CCC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2CC(O)C(=O)C1(C)C QZJJDOYZVRUEDY-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ZYZJWAJOTPNVPI-ZVBSCDOUSA-N cucurbitane Chemical class C([C@H]1[C@]2(C)CC[C@@H]([C@]2(CC[C@]11C)C)[C@H](C)CCCC(C)C)CC2[C@H]1CCCC2(C)C ZYZJWAJOTPNVPI-ZVBSCDOUSA-N 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- NDYMQXYDSVBNLL-LAMASETHSA-N (23E)-25-acetyloxy-2,16alpha,20-trihydroxy-9beta-methyl-19-nor-10alpha-lanosta-1,5,23-triene-3,11,22-trione Chemical compound C([C@H]1[C@]2(C)C[C@@H](O)[C@@H]([C@]2(CC(=O)[C@]11C)C)[C@@](C)(O)C(=O)C=CC(C)(C)OC(=O)C)C=C2[C@H]1C=C(O)C(=O)C2(C)C NDYMQXYDSVBNLL-LAMASETHSA-N 0.000 description 1
- NDYMQXYDSVBNLL-UHFFFAOYSA-N (9beta,10alpha,16alpha,23E)-25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C1C2C=C(O)C(=O)C1(C)C NDYMQXYDSVBNLL-UHFFFAOYSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- HAEQAUJYNHQVHV-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylbenzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 HAEQAUJYNHQVHV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101000654471 Mus musculus NAD-dependent protein deacetylase sirtuin-1 Proteins 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 108010041191 Sirtuin 1 Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000002351 beta-D-glucopyranosyloxy group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- PQOVWWZVVIGRPP-UHFFFAOYSA-N cucurbitacin B-glucoside Natural products CC12C(=O)CC3(C)C(C(C)(O)C(=O)C=CC(C)(C)OC(=O)C)C(O)CC3(C)C1CC=C(C(C1=O)(C)C)C2CC1OC1OC(CO)C(O)C(O)C1O PQOVWWZVVIGRPP-UHFFFAOYSA-N 0.000 description 1
- IVGSDBLLLAUYTL-UHFFFAOYSA-N cucurbitacin E Natural products CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C=C(O)C(=O)C4(C)C)C3(C)CCC12C IVGSDBLLLAUYTL-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- VARJMVYCDHQKCG-UHFFFAOYSA-N n-ethylpiperidin-4-amine Chemical compound CCNC1CCNCC1 VARJMVYCDHQKCG-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 150000002796 natural product derivatives Chemical class 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210097676.8A CN103360452B (zh) | 2012-04-04 | 2012-04-04 | 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210097676.8A CN103360452B (zh) | 2012-04-04 | 2012-04-04 | 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103360452A CN103360452A (zh) | 2013-10-23 |
CN103360452B true CN103360452B (zh) | 2016-02-24 |
Family
ID=49362787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210097676.8A Expired - Fee Related CN103360452B (zh) | 2012-04-04 | 2012-04-04 | 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103360452B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105859816B (zh) * | 2016-05-03 | 2018-04-10 | 浙江大学 | 火麻仁中提取β‑谷甾醇和β‑胡萝卜苷的方法、应用及产品 |
CN107686501B (zh) * | 2017-09-15 | 2020-05-22 | 浙江大学 | 葫芦烷型三萜化合物提取方法及其抗衰老医药用途 |
CN107857789B (zh) * | 2017-12-15 | 2020-11-20 | 黑龙江拜欧迪生物医药科技有限公司 | 葫芦素衍生物及其制备方法 |
CN116768955A (zh) * | 2022-03-09 | 2023-09-19 | 中国科学院上海药物研究所 | 一类葫芦素b衍生物及其制备方法和用途 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116404A2 (en) * | 2006-04-10 | 2007-10-18 | Bar-Ilan University | Cucurbitacin glucosides and use thereof in treating cancer |
US20090247495A1 (en) * | 2007-12-13 | 2009-10-01 | Wei Dong Xie | Cucurbitacin b and uses thereof |
CN101759746A (zh) * | 2009-11-24 | 2010-06-30 | 浙江工业大学 | 一种葫芦素b的提取分离方法 |
CN101759747A (zh) * | 2009-10-20 | 2010-06-30 | 苏州派腾生物医药科技有限公司 | 一种葫芦素e的制备方法 |
CN102274268A (zh) * | 2011-07-29 | 2011-12-14 | 哈尔滨医科大学 | 一种具有戒酒作用的中药活性提取物、其制备方法和应用 |
CN102297905A (zh) * | 2010-06-25 | 2011-12-28 | 沈阳药科大学 | 用手性柱分离鉴定及制备葫芦素混合物中单体物质的hplc方法 |
CN102336798A (zh) * | 2010-07-15 | 2012-02-01 | 栾德刚 | 人参皂苷Rh3的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101485705A (zh) * | 2007-09-14 | 2009-07-22 | 中国科学院昆明植物研究所 | 熟三七和熟三七标准提取物和其应用 |
CN102070695B (zh) * | 2010-12-10 | 2012-10-31 | 浙江大学 | 麦角甾醇衍生物的制备及应用 |
-
2012
- 2012-04-04 CN CN201210097676.8A patent/CN103360452B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116404A2 (en) * | 2006-04-10 | 2007-10-18 | Bar-Ilan University | Cucurbitacin glucosides and use thereof in treating cancer |
US20090247495A1 (en) * | 2007-12-13 | 2009-10-01 | Wei Dong Xie | Cucurbitacin b and uses thereof |
CN101759747A (zh) * | 2009-10-20 | 2010-06-30 | 苏州派腾生物医药科技有限公司 | 一种葫芦素e的制备方法 |
CN101759746A (zh) * | 2009-11-24 | 2010-06-30 | 浙江工业大学 | 一种葫芦素b的提取分离方法 |
CN102297905A (zh) * | 2010-06-25 | 2011-12-28 | 沈阳药科大学 | 用手性柱分离鉴定及制备葫芦素混合物中单体物质的hplc方法 |
CN102336798A (zh) * | 2010-07-15 | 2012-02-01 | 栾德刚 | 人参皂苷Rh3的合成方法 |
CN102274268A (zh) * | 2011-07-29 | 2011-12-14 | 哈尔滨医科大学 | 一种具有戒酒作用的中药活性提取物、其制备方法和应用 |
Non-Patent Citations (4)
Title |
---|
Isolation, Structure Elucidation, and Biological Evaluation of 16,23-Epoxycucurbitacin Constituents from Eleaocarpus chinensis;Li Pan 等;《Journal of Natural Products》;20120112;第75卷(第3期);第444-452页,尤其第445页化合物9和12 * |
New cucurbitacins from Phormium tenax and Marah oreganus;S. MORRIS KUPCHAN 等;《Phytochemistry》;19781231;第17卷(第4期);第767-769页,尤其第768页化合物7 * |
维药药西瓜化学成分的分离与鉴定;苗静 等;《中草药》;20120331;第43卷(第3期);第432-435页,尤其化合物7-11 * |
高速逆流色谱分离制备甜瓜蒂中葫芦素类化合物;金再宿 等;《分析化学》;20110630;第39卷(第6期);第867-871页,尤其图1中化合物 * |
Also Published As
Publication number | Publication date |
---|---|
CN103360452A (zh) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101279964B (zh) | 愈创木烷型倍半萜、其制备方法及其医药用途 | |
CN101747400A (zh) | 具抗肿瘤活性的羊毛甾烷型三萜化合物及制备方法和应用 | |
CN103360452B (zh) | 甜瓜蒂四环三萜葫芦素类化合物的制备和应用 | |
CN101185671B (zh) | 从核桃树皮中提取的抗肿瘤药物及其制备方法 | |
CN105859816B (zh) | 火麻仁中提取β‑谷甾醇和β‑胡萝卜苷的方法、应用及产品 | |
CN101648934A (zh) | 一种异戊烯基黄酮及其应用 | |
CN108210547A (zh) | 一种余甘子叶提取物的制备方法及其制剂与抗艾应用 | |
CN103342730B (zh) | 中药饿蚂蝗提取物的制备方法及其抗衰老用途 | |
CN101245089A (zh) | 一对新的人参皂苷元和其混合体的制备方法及其制剂 | |
TWI612963B (zh) | 具抗發炎與抑制肝癌細胞生長的蛹蟲草萃取物及其製備方法 | |
CN102295677B (zh) | 北美盐角草中一种降三萜皂苷及其制备方法和用途 | |
CN105012826A (zh) | 一种益智叶提取物及其制备方法、应用 | |
CN104945460A (zh) | 一种刺梨酸的制备方法及其应用 | |
CN105079011A (zh) | 一种具有抗肿瘤作用的药物的制备和应用 | |
CN103610682A (zh) | 3α-羟基-30-齐墩果-12,20(29)-二烯-28-酸的制备方法和在制备抗肿瘤药物中的应用 | |
CN103833823A (zh) | 二萜二聚体类化合物及其药物组合物和制备方法与应用 | |
CN103275139B (zh) | 十六碳双乙酰化一个双键内酯型槐糖脂及其应用 | |
CN103275138B (zh) | 十六碳双乙酰化无双键内酯型槐糖脂及其应用 | |
CN107686501B (zh) | 葫芦烷型三萜化合物提取方法及其抗衰老医药用途 | |
CN102362877A (zh) | 一种雾水葛提取物及其制备方法和应用 | |
CN105085221B (zh) | 具有抗真菌和抗肿瘤活性的化合物及其制备方法与应用 | |
CN101570485B (zh) | 一种长链脂肪酸的糖醇酯及其分离提取方法和在抑制芳香化酶活性中的应用 | |
CN116554254B (zh) | 一种具有镇静及缓解失眠作用的化合物及其应用 | |
CN104288142B (zh) | 木果楝素h及其类似物在制备抗抑郁症药物或食品中的用途 | |
CN103739548B (zh) | 具有抗真菌活性的化合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Applicant after: Zhejiang University Applicant after: Zhejiang Zuo Libaicao prepared slices of Chinese crude drugs company limited Address before: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Applicant before: Zhejiang University Applicant before: Zhejiang Baicao Traditional Chinese Medicine Pieces Co., Ltd. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160224 Termination date: 20170404 |